Choroidal Detachment Following the Use of Tamsulosin (Flomax)

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajo.2006.09.032 Byline: Brett L. Shapiro (a), Velimir Petrovic (b), Scott E. Lee (c), Allan Flach (c), Sharon McCaffery (c), Joan M. O'Brien (a)(c) Abstract: To report choroidal detachment following tamsulosin (Flomax, an [alpha].sub.1A-adrenoceptor antagonist) treatment of benign prostatic hyperplasia (BPH). Author Affiliation: (a) University of California San Francisco, School of Medicine, San Francisco, California (b) Kaiser Permanente, Sacramento, California (c) University of California San Francisco, Department of Ophthalmology, San Francisco, California Article History: Accepted 12 September 2006 Article Note: (footnote) This study was supported in part by a Lew R. Wasserman Merit Award from Research to Prevent Blindness, New York, New York. The authors indicate no financial conflict of interest. Involved in design of study (B.L.S., V.P., J.M.O.); Involved in collection, management, analysis and interpretation of data, and preparation of the data (B.L.S., V.P., S.E.L., A.F., S.M., J.M.O.); Involved in collection of data (B.L.S., V.P., S.E.L., S.M., J.M.O.); and involved in management, statistical analysis and interpretation of the data, and preparation of the manuscript (B.L.S., V.P., S.E.L., A.F., S.M., J.M.O.).